《API China 咨讯》印度制药企业欲通过产业链一体化，寻找中印合作最大公约数

According to a report from the Indian Medical Economics News, Dilip Surana, general manager of Microlabs, a leading export-oriented pharmaceutical company in India, pointed that the Indian pharmaceutical industry now has an excessive dependence on Chinese APIs.

来自《印度医药经济信息》的报道称，印度主要出口型制药公司麦克罗( Micro labs)总经理迪利普·苏拉纳( Dilip Surana)在接受媒体采访时指出，印度制药业对中国的原料药依然有巨大的依赖。

Dilip Surana said: " Since last year (2018), due to the increased supervision of China's environmental protection, the prices of some APIs and intermediates have skyrocketed, followed by frequent supply shortages. It has made huge influence in the market, not only in China but also in India. How to avoid the dilemma of the soaring price of APIs? Many Indian pharmaceutical companies, including Micro labs, have begun to find solutions.”

Dilip Surana表示:“自2018年以来，受中国环保治理监管力度加大影响，部分原料药、中间体价格暴涨，随之而来的是供应短缺频繁的困扰。这些变化不仅对中国制药产业影响巨大，并且对印度的制药业也有强烈的冲击。包括Mco在内的众多印度制药企业已着手策划应对战略。“

Picture from: Business Line

Driven by the strict national regulatory policies such as quality, environmental protection and safety, the industrial transformation and upgrading in China's API market has accelerated, and the company in market has improved its product quality and efficiency. As a result, the industry's competitive strength has rapidly increased.

中国原料药市场在质量、环保、安全等国家监管政策趋严强化的推动下，产业转型升级加快，企业提质增效增速，行业竞争实力增强。

At the same time, as an industry with an outward-looking competitive advantage, the internationalization strategy of APIs should be more stable in the future. Specifically, while abandoning the phenomenon of irregular competition in excessively low-priced exports, India and must adhere to the principle of mutual benefit for trading, focus on the fairness of transactions, follow the competition rules of complementary advantages to ensure market health.

与此同时，作为具有外向型竞争优势的产业，原料药国际化经营策略也宜更加稳健。具体来说就是，在摈弃过度压价出口的不规范竞争现象的同时，要坚持诚信互利的贸易原则，关注交易公平性;遵循优势互补的竞争规律，保证市场健康性。

Picture from: Pharma IQ

It is imperative to strengthen international cooperation in the production of APIs, especially to find the largest common denominator in the cooperation of APIs in China and India, and to maximize the mutual promotion. This requires serving customers with a more rational attitude, developing a community to sharing market interests, and promoting sustainable cooperation upstream and downstream

加强原料药产能国际合作已经势在必行，特别是寻找中印两国原料药市场合作的最大公约数，对于实现互促作用最大化举足轻重。这需要服务客户更加理性，发展市场利益共同体，推进可持续合作